In addition, EdU incorporation assay showed that HCC cells overexpressing ZYX had higher proliferation rates compared to the control, whereas ZYX knockdown slowed proliferation (Fig. 3B). The gene discussed is ZYX; the disease is hepatocellular carcinoma.